天山生物
(300313)
| 流通市值：19.54亿 | | | 总市值：23.74亿 |
| 流通股本：1.97亿 | | | 总股本：2.40亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 333,360,535.69 | 219,604,400.26 | 118,571,879.97 | 200,286,752.28 |
| 营业总成本 | 331,123,793.49 | 216,996,932.89 | 114,724,076.9 | 222,453,650.55 |
| 其他经营收益 | | | | |
| 营业利润 | 9,460,691.73 | 7,185,141.59 | 5,912,952.93 | -21,961,917.61 |
| 利润总额 | 9,198,936.83 | 7,073,775.84 | 5,900,480.59 | -21,960,276.1 |
| 净利润 | 6,259,693.01 | 5,322,917.95 | 4,843,727.11 | -26,189,029.43 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 6,259,693.01 | 5,322,917.95 | 4,843,727.11 | -26,189,029.43 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 130,184,298.77 | 116,732,669.17 | 114,578,855.16 | 101,886,304.14 |
| 非流动资产: | | | | |
| 非流动资产合计 | 175,594,118.59 | 176,920,980.85 | 180,528,488.21 | 177,745,189.96 |
| 资产总计 | 305,778,417.36 | 293,653,650.02 | 295,107,343.37 | 279,631,494.1 |
| 流动负债: | | | | |
| 流动负债合计 | 155,567,820.37 | 115,174,413.47 | 95,957,778.93 | 56,203,560.85 |
| 非流动负债: | | | | |
| 非流动负债合计 | 95,592,766.67 | 125,730,096.36 | 147,838,956.56 | 178,875,573.03 |
| 负债合计 | 251,160,587.04 | 240,904,509.83 | 243,796,735.49 | 235,079,133.88 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 39,369,076.61 | 38,270,473.4 | 36,740,100.4 | 31,644,037.14 |
| 股东权益合计 | 54,617,830.32 | 52,749,140.19 | 51,310,607.88 | 44,552,360.22 |
| 负债和股东权益合计 | 305,778,417.36 | 293,653,650.02 | 295,107,343.37 | 279,631,494.1 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 331,578,822.19 | 208,082,400.67 | 106,314,660.89 | 261,080,587.47 |
| 经营活动现金流出小计 | 353,294,813.59 | 219,286,245.8 | 121,327,985.44 | 259,134,183.03 |
| 经营活动产生的现金流量净额 | -21,715,991.4 | -11,203,845.13 | -15,013,324.55 | 1,946,404.44 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,625,911.78 | 1,272,036.69 | 236,260 | 3,162,070 |
| 投资活动现金流出小计 | 5,657,670.16 | 4,567,221.03 | 2,999,032 | 6,899,492.28 |
| 投资活动产生的现金流量净额 | -4,031,758.38 | -3,295,184.34 | -2,762,772 | -3,737,422.28 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 30,980,000 | 20,980,000 | 11,180,000 | 75,830,022 |
| 筹资活动现金流出小计 | 27,664,265.19 | 19,698,846.68 | 1,778,329.68 | 59,146,086.42 |
| 筹资活动产生的现金流量净额 | 3,315,734.81 | 1,281,153.32 | 9,401,670.32 | 16,683,935.58 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -22,432,014.97 | -13,217,876.15 | -8,374,426.23 | 14,892,917.74 |
| 期末现金及现金等价物余额 | 16,960,922.56 | 26,175,061.38 | 31,018,511.3 | 39,392,937.53 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -13,217,876.15 | - | 14,892,917.74 |